Human CX3CL1/Fractalkine DuoSet ELISA DY365 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemHuman CX3CL1/Fractalkine DuoSet ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $890.00Supplier Page View Company Product Page
Catalog NumberDY365
Quantity1 Kit (for 15 Plates)
ApplicationsELISA
Detection Range0.63 - 20 ng/mL
ReactivityHuman
Detection TargetCX3CL1/Fractalkine
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
NCBI Full Gene NameC-X3-C motif chemokine ligand 1
NCBI Gene AliasesABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT, SCYD1, fractalkine, neurotactin

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Inflammatory arthritis irAE may represent a unique autoimmune disease primarily driven by T cells but likely not autoantibodiesSci AdvApril 3, 2026Xingxing Zhu, Yue Yu, Shiju Chen, Hannah E. Langenfeld, Yanfeng Li, Panwen Wang, Ying Li, Chantal McCabe, Andrew C. Hanson, Brenna E. Sharp, et al.Human IL-21 DuoSet ELISA (R&D Systems, catalog no. DY8879-05), and Human CX3CL1/Fractalkine DuoSet ELISA (R&D Systems, DY365); all steps were performed according to the manufacturer’s instructions. The plates were read at 450

(2) Inflammatory arthritis immune related adverse events represent a unique autoimmune disease entity primarily driven by T cells, but likely not autoantibodiesmedRxiv : the preprint server for health sciencesSeptember 26, 2025Zhu X, Yu Y, Li Y, Wang P, Li Y, McCabe C, Chen S, Langenfeld HE, Hanson AC, Sharp BE, et al.

(3) Exploring chemokines and soluble adhesion molecules in mustard lung pathogenesisInternational immunopharmacologyMarch 6, 2025Rezaei A, Pourfarzam S, Jamali T, Mohammadi NG, Andalib A, Hassan ZM, Ayubi F, Ghazanfari T.

(4) Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver DiseaseInternational journal of molecular sciencesJune 20, 2023Fiorillo A, Gallego JJ, Casanova-Ferrer F, Giménez-Garzó C, Urios A, Ballester MP, Durbán L, Rios MP, Megías J, San Miguel T, et al.

(5) Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 SecretionCancersMay 4, 2023Bruss C, Kellner K, Albert V, Hutchinson JA, Seitz S, Ortmann O, Brockhoff G, Wege AK.

(6) Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional ChondrosarcomaClinical cancer research : an official journal of the American Association for Cancer ResearchDecember 1, 2021Li B, Li G, Yan X, Zhu D, Lin PP, Wang Z, Qu H, He X, Fu Y, Zhu X, et al.#DY210, #DY217B, #DY1164, #DY350, #DY350, #DY279, #DY208, #DY266, #DY392, #DY317, #DY278, #DY281, and #DY365; R&D Systems) following the manufacturer's instructions. D-2-Hydroxyglutarate concentration evaluation D-2-Hydroxyglutarate

(7) CX3CL1 Overexpression Prevents the Formation of Lung Metastases in Trastuzumab-Treated MDA-MB-453-Based Humanized Tumor Mice (HTM)CancersMay 18, 2021Wege AK, Dreyer TF, Teoman A, Ortmann O, Brockhoff G, Bronger H.

(8) A digital single-molecule nanopillar SERS platform for predicting and monitoring immune toxicities in immunotherapyNature communicationsFebruary 17, 2021Li J, Wuethrich A, Sina AAI, Cheng HH, Wang Y, Behren A, Mainwaring PN, Trau M.anti-CX3CL1 (AF-365) antibodies; and FGF-2 (DY233-05), G-CSF (DY214-05), GM-CSF (DY215-05), and CX3CL1 (DY365) ELISA kits were bought from R&D Systems. All the patient serum or plasma samples were collected at

(9) High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patientsEBioMedicineDecember 1, 2020Yeregui E, Viladés C, Domingo P, Ceausu A, Pacheco YM, Veloso S, Inciarte A, Vidal-González J, Peraire M, Perpiñán C, et al.one-step process enzyme-linked immunosorbent assay (ELISA) with DuoSet DY350 (R&D Systems Inc), DuoSet DY365 (R&D Systems Inc), BMS281INST (eBioscience, The Affymetrix company), DuoSet DY270 (R&D Systems Inc)

(10) Effects of an 8-Week Protein Supplementation Regimen with Hyperimmunized Cow Milk on Exercise-Induced Organ Damage and Inflammation in Male Runners: A Randomized, Placebo Controlled, Cross-Over StudyBiomedicinesMarch 4, 2020Ma S, Tominaga T, Kanda K, Sugama K, Omae C, Hashimoto S, Aoyama K, Yoshikai Y, Suzuki K.

(11) ADAM-17 is expressed on rheumatoid arthritis fibroblast-like synoviocytes and regulates proinflammatory mediator expression and monocyte adhesionArthritis research & therapyAugust 2, 2018Ishii S, Isozaki T, Furuya H, Takeuchi H, Tsubokura Y, Inagaki K, Kasama T.

(12) Elevated levels of soluble fractalkine and increased expression of CX3CR1 in neuropsychiatric systemic lupus erythematosusExperimental and Therapeutic MedicineOctober 1, 2017Ling Guo, Xiaoye Lu, Yuan Wang, Chunde Bao, Shunle Chenmedical records. Levels of sFKN in serum and CSF were evaluated using an enzyme‑linked immunosorbent assay (DY365) and substrate kit (DY999; R&D Systems, Inc., Minneapolis, MN, USA). mRNA expression of FKN and CX3CR1

(13) Glycogen synthase kinase-3β regulates fractalkine production by altering its trafficking from Golgi to plasma membrane: implications for Alzheimer's diseaseCellular and molecular life sciences : CMLSMarch 1, 2017Fuster-Matanzo A, Jurado-Arjona J, Benvegnù S, García E, Martín-Maestro P, Gómez-Sintes R, Hernández F, Ávila J.

(14) Fractalkine shedding is mediated by p38 and the ADAM10 protease under pro-inflammatory conditions in human astrocytesJournal of neuroinflammationAugust 22, 2016O'Sullivan SA, Gasparini F, Mir AK, Dev KK.were measured with human CX3CL1 ELISA kit according to the manufacturer’s instructions (R&D Systems; DY365). This DuoSet detects the N-terminal chemokine domain of human fractalkine. The level of detection for

(15) CX3CL1 expression in the conjunctiva is involved in immune cell trafficking during toxic ocular surface inflammationMucosal immunologyNovember 1, 2012Denoyer A, Godefroy D, Célérier I, Frugier J, Riancho L, Baudouin F, Rostène W, Baudouin C.Enzyme-linked immunosorbent assay. The release of CX3CL1 in cell supernatants of human IOBA-NHC cells was measured by an ELISA kit (DY365, R&D Systems). The 96-well microtiter plates were coated overnight with capture monoclonal antibody

(16) Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activityArthritis research & therapyMarch 6, 2012Suzuki F, Kubota T, Miyazaki Y, Ishikawa K, Ebisawa M, Hirohata S, Ogura T, Mizusawa H, Imai T, Miyasaka N, et al.

(17) Changes of dendritic cells and fractalkine in type 2 diabetic patients with unstable angina pectoris: a preliminary reportCardiovascular DiabetologyDecember 1, 2011Kang Yao, Hao Lu, Rongchong Huang, Shuning Zhang, Xiaowu Hong, Hongyu Shi, Aijun Sun, Juying Qian, Yunzeng Zou, Junbo GeBioRad Variant System. The serum level of FKN was analyzed using enzyme-linked immunosorbent assay kits (DY365 DuoSet System, R&D Systems) according to the manufacturer's instructions. The serum level of IL-12 and

(18) Thromboxane prostanoid receptor stimulation induces shedding of the transmembrane chemokine CX3CL1 yet enhances CX3CL1-dependent leukocyte adhesionAmerican journal of physiology. Cell physiologyJune 1, 2010Tole S, Durkan AM, Huang YW, Liu GY, Leung A, Jones LL, Taylor JA, Robinson LA.

(19) Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatmentJournal of neuroimmunologyMay 29, 2009Hurst LA, Bunning RA, Couraud PO, Romero IA, Weksler BB, Sharrack B, Woodroofe MN.

(20) The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cellsCancer lettersJanuary 8, 2009Nevo I, Sagi-Assif O, Meshel T, Ben-Baruch A, Jöhrer K, Greil R, Trejo LE, Kharenko O, Feinmesser M, Yron I, et al.